精神神经因素在银屑病发病中的作用

doi:10.3760/cma.j.issn.0412-4030.2019.03.013

中华皮肤科杂志 ›› 2019, Vol. 52 ›› Issue (3): 204-207.doi: 10.3760/cma.j.issn.0412-4030.2019.03.013

精神神经因素在银屑病发病中的作用

高祎濛晋红中

中国医学科学院北京协和医学院北京协和医院皮肤科 100730

收稿日期:2018-03-12 修回日期:2018-11-27 发布日期:2019-03-04
通讯作者: 晋红中 E-mail:jinhongzhong@263.net
基金资助:
中央保健科研课题（W2017BJ21）；

首都卫生发展科研专项（首发2016?2?4018）

The role of neuropsychiatric factors in the occurrence of psoriasis

Gao Yimeng, Jin Hongzhong

Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

Received:2018-03-12 Revised:2018-11-27 Published:2019-03-04
Contact: Jin Hongzhong E-mail:jinhongzhong@263.net
Supported by:
Central Health Care Research Fund of China （W2017BJ21）;

Capitals Funds for Health Improvement and Research （2016?2?4018）

摘要/Abstract

摘要： 【摘要】大量证据表明精神因素如焦虑、紧张、精神应激等可以诱发或加重银屑病，还可以在一定程度上影响银屑病的治疗效果，提示精神因素可能在银屑病发病中起到重要作用。目前关于银屑病精神神经相关发病机制的研究主要体现在以下两方面，一方面精神因素作为应激源，引起下丘脑-垂体-肾上腺皮质轴与交感神经-肾上腺髓质系统两大神经内分泌系统的激活；另一方面神经肽及神经生长因子诱导体内的神经源性炎症反应。精神神经因素可能通过以上途径共同参与银屑病发病。

关键词: 银屑病；焦虑；应激, 心理学；神经肽类；神经生长因子类；下丘脑-垂体-肾上腺皮质轴；交感神经-肾上腺髓质系统

Abstract: 【Abstract】 Considerable evidence has indicated that psychological factors, such as anxiety, nervousness and mental stress, can induce or exacerbate psoriasis and affect therapeutic effects to a certain degree, suggesting that psychological factors may play an important role in the occurrence of psoriasis. Current researches on neuropsychiatry-related pathogenesis of psoriasis mainly include two aspects: on the one hand, acting as stressors, psychological factors can activate the following two neuroendocrine systems, including hypothalamic-pituitary-adrenocortical axis and sympathetic-adrenal medullary system; on the other hand, neuropeptides and nerve growth factors induce in vivo neurogenic inflammation. Neuropsychiatric factors may participate in the occurrence of psoriasis through the above pathways.

Key words: Psoriasis, Anxiety, Stress, psychological, Neuropeptides, Nerve growth factors, Hypothalamic?pituitary?adrenocortical axis, Sympathetic?adrenal medullary system

高祎濛晋红中. 精神神经因素在银屑病发病中的作用[J]. 中华皮肤科杂志, 2019,52(3):204-207. doi:10.3760/cma.j.issn.0412-4030.2019.03.013

Gao Yimeng, Jin Hongzhong. The role of neuropsychiatric factors in the occurrence of psoriasis[J]. Chinese Journal of Dermatology, 2019, 52(3): 204-207.doi:10.3760/cma.j.issn.0412-4030.2019.03.013

参考文献 42

［1］	Manolache L, Petrescu⁃Seceleanu D, Benea V. Life events involvement in psoriasis onset/recurrence［J］. Int J Dermatol, 2010,49（6）:636⁃641. doi: 10.1111/j.1365⁃4632.2009.04367.x.
［2］	Malhotra SK, Mehta V. Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria［J］. Indian J Dermatol Venereol Leprol, 2008,74（6）:594⁃599.
［3］	Verhoeven EW, Kraaimaat FW, de Jong EM, et al. Individual differences in the effect of daily stressors on psoriasis: a prospective study［J］. Br J Dermatol, 2009,161（2）:295⁃299. doi: 10.1111/j.1365⁃2133.2009.09194.x.
［4］	Chen K, Wang G, Jin H, et al. Clinic characteristics of psoriasis in China: a nationwide survey in over 12 000 patients［J］. Oncotarget, 2017,8（28）:46381⁃46389. doi: 10.18632/oncotarget. 18453.
［5］	Yan D, Afifi L, Jeon C, et al. A cross⁃sectional study of psoriasis triggers among different ethno⁃racial groups［J］. J Am Acad Dermatol, 2017,77（4）:756⁃758.e1. doi: 10.1016/j.jaad.2017.04. 1109.
［6］	Kouris A, Platsidaki E, Kouskoukis C, et al. Psychological parameters of psoriasis［J］. Psychiatriki, 2017,28（1）:54⁃59. doi: 10.22365/jpsych.2017.281.54.
［7］	Fortune DG, Richards HL, Kirby B, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy［J］. Arch Dermatol, 2003,139（6）:752⁃756. doi: 10.1001/archderm.139.6.752.
［8］	Snast I, Reiter O, Atzmony L, et al. Psychological stress and psoriasis: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2018,178（5）:1044⁃1055. doi: 10.1111/bjd.16116.
［9］	Hunter HJ, Griffiths CE, Kleyn CE. Does psychosocial stress play a role in the exacerbation of psoriasis?［J］. Br J Dermatol, 2013,169（5）:965⁃974. doi: 10.1111/bjd.12478.
［10］	Alexopoulos A, Chrousos GP. Stress⁃related skin disorders［J］. Rev Endocr Metab Disord, 2016,17（3）:295⁃304. doi: 10.1007/s11154⁃016⁃9367⁃y.
［11］	Chen Y, Lyga J. Brain⁃skin connection: stress, inflammation and skin aging［J］. Inflamm Allergy Drug Targets, 2014,13（3）:177⁃190.
［12］	Bilgiç Ö, Bilgiç A, Sivrikaya A, et al. Association between endocrinological, immunological and psychosocial variables in psoriasis patients［J］. G Ital Dermatol Venereol, 2016,151（6）:603⁃609.
［13］	Evers AW, Verhoeven EW, Kraaimaat FW, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis［J］. Br J Dermatol, 2010,163（5）:986⁃991. doi: 10.1111/j.1365⁃2133.2010. 09984.x.
［14］	Brunoni AR, Santos IS, Sabbag C, et al. Psoriasis severity and hypothalamic⁃pituitary⁃adrenal axis function: results from the CALIPSO study［J］. Braz J Med Biol Res, 2014,47（12）:1102⁃1106. doi:10.1590/1414⁃431X20143762
［15］	Karanikas E, Harsoulis F, Giouzepas I, et al. Stimulation of the hypothalamic⁃pituitary⁃adrenal axis with corticotropin releasing hormone in patients with psoriasis［J］. Hormones （Athens）, 2007,6（4）:314⁃320.
［16］	Theoharides TC, Stewart JM, Taracanova A, et al. Neuroendo⁃crinology of the skin［J］. Rev Endocr Metab Disord, 2016,17（3）:287⁃294. doi: 10.1007/s11154⁃016⁃9369⁃9.
［17］	Slominski AT, Zmijewski MA, Zbytek B, et al. Key role of CRF in the skin stress response system［J］. Endocr Rev, 2013,34（6）:827⁃884. doi: 10.1210/er.2012⁃1092.
［18］	Zhou CL, Yu XJ, Cai DX, et al. Inhibiting interleukin⁃18 production through the mitogen⁃activated protein kinase pathway, a potential role of corticotropin⁃releasing hormone in chronic plaque psoriasis［J］. Inflammation, 2015,38（3）:1003⁃1011. doi: 10.1007/s10753⁃014⁃0064⁃2.
［19］	Zhou C, Yu X, Cai D, et al. Role of corticotropin⁃releasing hormone and receptor in the pathogenesis of psoriasis［J］. Med Hypotheses, 2009,73（4）:513⁃515. doi: 10.1016/j.mehy.2009.02. 051.
［20］	Cemil BC, Canpolat F, Yilmazer D, et al. The association of PASI scores with CRH⁃R1 in patients with psoriasis［J］. Arch Dermatol Res, 2012,304（2）:127⁃132. doi: 10.1007/s00403⁃012⁃1218⁃4.
［21］	Vasiadi M, Therianou A, Sideri K, et al. Increased serum CRH levels with decreased skin CRHR⁃1 gene in psoriasis and atopic dermatitis［J］. J Allergy Clin Immunol, 2012,129（5）:1410⁃1413. doi: 10.1016/j.jaci.2012.01.041.
［22］	Loite U, Kingo K, Reimann E, et al. Gene analysis of the corticotrophin⁃releasing hormone⁃proopiomelanocortin system in psoriasis skin biopsies［J］. Acta Derm Venereol, 2013,93（4）:400⁃405. doi: 10.2340/00015555⁃1524.
［23］	Lee JH, Cho DH, Park HJ. IL⁃18 and cutaneous inflammatory diseases［J］. Int J Mol Sci, 2015,16（12）:29357⁃29369. doi: 10.3390/ijms161226172.
［24］	Vandevyver S, Dejager L, Tuckermann J, et al. New insights into the anti⁃inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid⁃receptor⁃mediated transacti⁃vation［J］. Endocrinology, 2013,154（3）:993⁃1007. doi: 10.1210/en.2012⁃2045.
［25］	Man XY, Li W, Chen JQ, et al. Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes［J］. Cell Mol Life Sci, 2013,70（12）:2205⁃2220. doi: 10.1007/s00018⁃012⁃1255⁃3.
［26］	Hannen R, Udeh⁃Momoh C, Upton J, et al. Dysfunctional skin⁃derived glucocorticoid synthesis is a pathogenic mechanism of psoriasis［J］. J Invest Dermatol, 2017,137（8）:1630⁃1637. doi: 10.1016/j.jid.2017.02.984.
［27］	Madva EN, Granstein RD. Nerve⁃derived transmitters including peptides influence cutaneous immunology［J］. Brain Behav Immun, 2013,34:1⁃10. doi: 10.1016/j.bbi.2013.03.006.
［28］	Schallreuter KU, Wood JM, Lemke R, et al. Production of catecholamines in the human epidermis［J］. Biochem Biophys Res Commun, 1992,189（1）:72⁃78.
［29］	Stohl LL, Zang JB, Ding W, et al. Norepinephrine and adenosine⁃5′⁃triphosphate synergize in inducing IL⁃6 production by human dermal microvascular endothelial cells［J］. Cytokine, 2013,64（2）:605⁃612. doi: 10.1016/j.cyto.2013.08.005.
［30］	Zhou J, Yan J, Liang H, et al. Epinephrine enhances the response of macrophages under LPS stimulation［J］. Biomed Res Int, 2014,2014:254686. doi: 10.1155/2014/254686.
［31］	Gupta K, Harvima IT. Mast cell⁃neural interactions contribute to pain and itch［J］. Immunol Rev, 2018,282（1）:168⁃187. doi: 10.1111/imr.12622.
［32］	Zhu TH, Nakamura M, Farahnik B, et al. The role of the nervous system in the pathophysiology of psoriasis: a review of cases of psoriasis remission or improvement following denervation injury［J］. Am J Clin Dermatol, 2016,17（3）:257⁃263. doi: 10.1007/s40257⁃016⁃0183⁃7.
［33］	Keçici AS, Göktay F, Tutkavul K, et al. Unilateral improvement of nail psoriasis with denervation injury［J］. Clin Exp Dermatol,2018,43（3）:339⁃341. doi: 10.1111/ced.13337.
［34］	Szepietowski JC, Reich A. Pruritus in psoriasis: an update［J］. Eur J Pain, 2016,20（1）:41⁃46. doi: 10.1002/ejp.768.
［35］	Kubanov AA, Katunina OR, Chikin VV. Expression of neuropeptides, neurotrophins, and neurotransmitters in the skin of patients with atopic dermatitis and psoriasis［J］. Bull Exp Biol Med, 2015,159（3）:318⁃322. doi: 10.1007/s10517⁃015⁃2951⁃4.
［36］	Lotti T, D′Erme AM, Hercogová J. The role of neuropeptides in the control of regional immunity［J］. Clin Dermatol, 2014,32（5）:633⁃645. doi: 10.1016/j.clindermatol.2014.04.011.
［37］	Ostrowski SM, Belkadi A, Loyd CM, et al. Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflam⁃mation in a sensory neuropeptide⁃dependent manner［J］. J Invest Dermatol, 2011,131（7）:1530⁃1538. doi: 10.1038/jid.2011.60.
［38］	Ding W, Stohl LL, Xu L, et al. Calcitonin gene⁃related peptide⁃exposed endothelial cells bias antigen presentation to CD4+ T cells toward a Th17 response［J］. J Immunol, 2016,196（5）:2181⁃2194. doi: 10.4049/jimmunol.1500303.
［39］	Ding W, Manni M, Stohl LL, et al. Pituitary adenylate cyclase⁃activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells［J］. Eur J Immunol, 2012,42（4）:901⁃911. doi: 10.1002/eji.201141958.
［40］	Zhang J, Ma WY. Nerve growth factor regulates the of vascular endothelial growth factor in human HaCaT keratinocytes via PI3K/mTOR pathway［J］. Genet Mol Res, 2014,13（4）:9324⁃9335. doi: 10.4238/2014.January.24.14.
［41］	Brunoni AR, Lotufo PA, Sabbag C, et al. Decreased brain⁃derived neurotrophic factor plasma levels in psoriasis patients［J］. Braz J Med Biol Res, 2015,48（8）:711⁃714. doi: 10.1590/1414⁃431X2015 4574.
［42］	Truzzi F, Marconi A, Atzei P, et al. p75 neurotrophin receptor mediates apoptosis in transit⁃amplifying cells and its overexp⁃ression restores cell death in psoriatic keratinocytes［J］. Cell Death Differ, 2011,18（6）:948⁃958. doi: 10.1038/cdd.2010.162.

精神神经因素在银屑病发病中的作用

The role of neuropsychiatric factors in the occurrence of psoriasis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 42

相关文章 0

Metrics

本文评价

推荐阅读 10